Inventor · disambiguated record
Yvonne Alice Nagel
Also filed as: NAGEL YVONNE ALICE
7 granted patents·11 pending applications·22 citations·filing 2014–2025
81Inventor score
Top patents by PatentIndex Score
18 records- 0196US12209091B2Isoindolinone derivatives as selective allosteric inhibitors of Egfr mutant cancersHOFFMANN LA ROCHE·Filed 2020·Granted Jan 28, 2025·7 cites·30 claims
- 0294US11708354B22-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compoundsHOFFMANN LA ROCHE·Filed 2020·Granted Jul 25, 2023·3 cites·16 claims
- 0392US12344613B2EGFR inhibitor for the treatment of cancerHOFFMANN LA ROCHE·Filed 2020·Granted Jul 1, 2025·3 cites·10 claims
- 0487US10882848B22-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compoundsHOFFMANN LA ROCHE·Filed 2019·Granted Jan 5, 2021·3 cites·15 claims
- 0586US11117890B2Substituted isoindole allosteric EGFR inhibitorsHOFFMANN LA ROCHE·Filed 2019·Granted Sep 14, 2021·3 cites·21 claims
- 0678US2025289824A1Egfr inhibitor for the treatment of cancerHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 0772US2022135571A1Therapeutic egfr inhibitorsHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 0869US10227390B2Stabilized polypeptide insulin receptor modulatorsHARVARD COLLEGE·Filed 2014·Granted Mar 12, 2019·3 cites·16 claims
- 0965US12479849B2EGFR inhibitors for the treatment of cancerHOFFMANN LA ROCHE·Filed 2020·Granted Nov 25, 2025·0 cites·8 claims
- 1065US2022112199A1Egfr inhibitor for medical useHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 1162US2025313565A1New indazole derivativesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1258US2022315591A1New egfr inhibitorsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1354US2023034696A1Egfr inhibitorsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1452US2023057891A1Egfr inhibitorsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1551US2022315577A1New egfr inhibitorsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1651US2020308171A1Bifunctional inhibitors with egfr having a e3 ubiquitin ligase moietyHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1751US2020361930A1Bifunctional molecules that degrade egfrHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1845US2016244494A1Stabilized polypeptides and uses thereofHARVARD COLLEGE·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yvonne Alice Nagel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →